Two popular slimming drugs have been taken off the market worldwide following
new evidence that they can cause heart problems. In one study, 30 per cent of
people taking fenfluramine or dexfenluramine, also known as Redux, showed signs
of abnormal heart valve function. Neuroscientists have also expressed concern
that the drugs could damage the brain
(This Week, 28 June, p 10).
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features

Environment
Evocative photos of Canadian Arctic win New ¾«¶«´«Ã½ Editors Award
Regulars

Environment
June heatwave may have killed around 20,000 people in Europe
News

Physics
Random wobbles in time could finally solve gravity’s greatest mystery
News

Life
Synthetic biology may finally be ready to solve life's biggest mystery
Leader
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Humans sleep the least of all apes – is it the secret to our success?
2
Random wobbles in time could finally solve gravity’s greatest mystery
3
The weirdness of neutrinos could completely rewrite particle physics
4
The 4 must-watch science-fiction films of the year so far
5
The world's fastest spider tops 3.5 metres per second
6
A type of fibre that stimulates GLP-1 release approved for use in food
7
June heatwave may have killed around 20,000 people in Europe
8
What is 'SpudCell'? Arguably the greatest bioengineering feat yet
9
The best new science-fiction novels published in July 2026
10
The best new popular science books of July 2026